Glessner Coleen's Form 4 filing
Emergent BioSolutions Inc. (EBS) · filed Oct 16, 2025
- Accession no.
- 0001919170-25-000004
- Filed
- Oct 16, 2025
- Trade date
- Oct 7, 2025
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $306.1K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glessner ColeenCIK 0001919170 | Officer (EVP, Quality & Ethics, and CPL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Common Stock | SSaleDisposed | −30,608 | $10.00 | −$306,080 | 144,319 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.